Search Results - "ÜNAL, Olçun Ümit"

Comparison of oral capecitabine alone versus platinum combinations in elderly metastatic gastric cancer patients by DEĞİRMENCİOĞLU, Serkan, ÜNAL, Olçun Ümit, OKTAY, Esin

“…Background: Gastric cancer is responsible for a considerable proportion of all cancer-related deaths. Elderly cancer patients are often ignored in prospective…”
Get full text

A rare tumor of the pancreas: Anaplastic carcinoma by ÜREYEN, Orhan, ÜNAL, Olçun Ümit, ALAY, Demet, YAĞCI, Ayşe, İLHAN, Enver

“…Anaplastic carcinoma of the pancreas is rarely encountered and usually reported as case reports in the literature. Anaplastic carcinoma is prognosed worse than…”
Get full text

The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study by Caliskan Yildirim, Eda, Atag, Elif, Coban, Ezgi, Umit Unal, Olcun, Celebi, Abdussamet, Keser, Murat, Uzun, Mehmet, Keskinkilic, Merve, Tanrikulu Simsek, Eda, Sari, Murat, Yavuzsen, Tugba

“…CDK4/6 inhibitors combined with endocrine therapy have significantly improved treatment outcomes for metastatic hormone receptor-positive (HR+) breast cancer…”
Get full text

The correlates of benefit from neoadjuvant chemotherapy before surgery in non-small-cell lung cancer: a metaregression analysis by Bozcuk, Hakan, Abali, Huseyin, Coskun, Senol

“…Although neoadjuvant chemotherapy (NCT) is widely used, it is not clear which subgroup of locally advanced non-small-cell lung cancer (NSCLC) patients should…”
Get full text

Clinicopathological characteristics and prognosis of patients according to recurrence time after radical nephrectomy for localized renal cell carcinoma: a multicenter study of Anatolian Society of Medical Oncology (ASMO) by Bozkurt, Oktay, Inanc, Mevlüde, Hacibekıroglu, Ilhan, Esbah, Onur, Seker, Metın, Ulas, Arıfe, Aydin, Kübra, Uysal, Mükremın, Kücüköner, Mehmet, Uncu, Dogan, Cıltas, Aydin, Unal, Olcun Ümıt, Durnali, Ayse, Demırcı, Umut, Berk, Velı, Tonyali, Onder, Oksüzoglu, Berna, Karaca, Halıt, Ozkan, Metın

“…We investigated the clinicopathological features in patients with recurrent RCC within 5 years or more than 5 years after nephrectomy and determined predictors…”
Get full text

Does immunohistochemical marker conversion affect the prognosis in breast cancer patients receiving neoadjuvant chemotherapy? by Uzun, Mehmet, Atag, Elif, Caliskan Yildirim, Eda, Keser, Murat, Semiz, Huseyin Salih, Unal, Olcun Umit

“…Biomarkers such as hormone receptors (HR) and human epidermal growth factor receptor2 (HER2) may change after neoadjuvant chemotherapy (NAC) in breast cancer…”
Get full text

Küçük hücreli dışı akciğer kanseri hastalarında EGFR mutasyon durumu ile klinikopatolojik özelliklerin korelasyonu by Ünal, Olçun Ümit

“…Giriş ve Amaç: Bu araştırmada KHDAK hastalarında EGFR ekzon 18, 19, 20, 21 ekzon mutasyonu analizi ile klinikopatolojik özellikleri ve prognozun kıyaslanması…”
Get full text

FOLFOX7 regimen in the first-line treatment of metastatic colorectal cancer by Koca, Doğan, Ünal, Olçun Ümit, Öztop, Ilhan, Yılmaz, Uğur

“…We aimed to investigate the efficacy and tolerability of a FOLFOX7 regimen in the first-line treatment of metastatic colorectal cancer (mCRC) patients…”
Get full text

Efficacy of everolimus plus hormonal treatment after cyclin-dependent kinase inhibitor; real-life experience, A TOG study by Beypınar, İsmail, Demir, Hacer, Yaslıkaya, Şendağ, Köşeci, Tolga, Demir, Bilgin, Çolak, Gökhan, Ağaoğlu, Ahmet Burak, Şahbazlar, Mustafa, Şancı, Pervin Can, Çabuk, Devrim, Işık, Ulaş, Şahin, Elif, Coşkun, Alper, Caner, Burcu, Aykut, Talat, Artaç, Mehmet, Duygulu, Mustafa Emre, Sever, Nadiye, Öksüz, Sıla, Turan, Nedim, Aykan, Musa Barış, Tüzün, Esmanur Kaplan, Uysal, Mükremin, Uğurlu, İrem, Sakin, Abdullah, Acar, Caner, Özaşkın, Duygu, Şakalar, Teoman, Keskinkılıç, Merve, Yavuzşen, Tuğba, Köse, Naziyet, Ertürk, İsmail, Yıldırım, Nilgün, Balçık, Onur Yazdan, Alkan, Ali, Selvi, Oğuzhan, Erçin, Eda, Ünal, Olçun Ümit, Karaçin, Cengiz

“…Purpose In advanced breast cancer, endocrine therapy is preferred in the absence of visceral crisis. Cyclin-dependent kinase inhibitors (CDKi) are the gold…”
Get full text

Survival outcomes according to the tumor location and prognostic factor in metastatic rectal cancer: a multicenter retrospective cohort study by Unal, Olcun Umit, Akay, Seval, Semiz, Huseyin Salih, Keser, Murat, Demir, Gonul, Capar, Zeliha Guzeloz, Demirciler, Erkut, Yavuzsen, Tugba, Degirmencioglu, Serkan, Demir, Bilgin, Oktay, Esin, Gulmez, Meltem Demirtas, Arayici, Mehmet Emin

“…Prognostic factors of metastatic rectal cancer are not well known. We aim to determine prognostic factors affecting survival for metastatic rectal cancer…”
Get full text

EGFR mutation status in a series of Turkish non-small cell lung cancer patients by Calibasi-Kocal, Gizem, Amirfallah, Arsalan, Sever, Tolga, Unal, Olcun Umit, Gurel, Duygu, Oztop, Ilhan, Ellidokuz, Hulya, Basbinar, Yasemin

“…Epidermal growth factor receptor (EGFR) mutations are potential markers driving carcinogenesis, and may alter the response to EGFR tyrosine kinase inhibitors…”
Get full text

Effective Treatment of Undiferentiated Pleomorphic Sarcoma Using Gemcitabine: A Case Report by Ünal, Olçun Ümit, Vardar, Enver, Acar, Türker, Vardar, Ufuk, Yildirim, Mehmet

“…Undifferentiated pleomorphic sarcoma (UPS) is most frequently observed in the extremities but rarely in the retroperitoneum. The present treatment for patients…”
Get full text

XELOX vs. FOLFOX4 as second line chemotherapy in advanced pancreatic cancer by Berk, Veli, Ozdemir, Nuriye, Ozkan, Metin, Aksoy, Sercan, Turan, Nedim, Inal, Ali, Balakan, Ozan, Yasar, Nurgul, Unal, Olcun Umit, Benekli, Mustafa, Durnali, Ayse, Colak, Dilsen, Sonmez, Ozlem Uysal

“…The efficacy and tolerability of oxaliplatin in combination with either folinic acid, fluoro-uracil (5-FU) (FOLFOX4 regimen) or capecitabine (XE-LOX regimen)…”
Get more information

Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology by Berk, Veli, Kaplan, Mehmet Ali, Tonyali, Onder, Buyukberber, Suleyman, Balakan, Ozan, Ozkan, Metin, Demirci, Umut, Ozturk, Turkan, Bilici, Ahmet, Tastekin, Didem, Ozdemir, Nuriye, Unal, Olcun Umit, Oflazoglu, Utku, Turkmen, Esma, Erdogan, Bulent, Uyeturk, Ummugul, Oksuzoglu, Berna, Cinkir, Havva Yesil, Yasar, Nurgul, Gumus, Mahmut

“…Inoperable and metastatic hepatocellular carcinoma (HCC) is associated with a poor prognosis and low chemotherapeutic efficiency. Sorafenib is an oral…”
Get full text

Bimonthly regimen of high-dose leucovorin, infusional 5-fluorouracil, docetaxel, and cisplatin (modified DCF) in advanced gastric adenocarcinoma by Unek, Ilkay Tugba, Akman, Tulay, Oztop, Ilhan, Unal, Olcun Umit, Salman, Tarik, Yilmaz, Ugur

“…Background The combination of docetaxel, cisplatin, and 5-fluorouracil (DCF) is an effective but highly toxic regimen for the treatment of advanced gastric…”
Get full text

Biological subtypes and survival outcomes in breast cancer patients with brain metastases (study of the Anatolian Society of Medical Oncology) by Kaplan, Muhammet Ali, Isikdogan, Abdurrahman, Koca, Doğan, Kucukoner, Mehmet, Gumusay, Ozge, Yildiz, Ramazan, Dayan, Adem, Demir, Lütfiye, Geredeli, Caglayan, Kocer, Murat, Arslan, Ulku Yalcintas, Inal, Ali, Unal, Olcun Umit, Mert, Aslıhan Guven, Bilici, Mehmet, Ozkan, Metin, Elkiran, Emin Tamer, Yaman, Sebnem, Durnalı, Ayse Gok, Suner, Ali, Alici, Suleyman, Tarhan, Mustafa Oktay, Boruban, Cem, Urakci, Zuhat, Buyukberber, Suleyman

“…The aim of this study is to determine the relationship between the survival outcomes and biological subtype in breast cancer patients with brain metastases. We…”
Get more information

Clinicopathologic characteristics, treatment outcomes, and prognostic factors of primary thoracic soft tissue sarcoma: A multicenter study of the Anatolian Society of Medical Oncology (ASMO) by Unal, Olcun Umit, Oztop, Ilhan, Yasar, Nurgul, Urakci, Zuhat, Ozatli, Tahsin, Bozkurt, Oktay, Sevinc, Alper, Gunaydin, Yusuf, Yapar Taskoylu, Burcu, Arpaci, Erkan, Ulas, Arife, Kodaz, Hilmi, Tonyali, Onder, Avci, Nilufer, Aksoy, Asude, Yilmaz, Ahmet Ugur

“…Background Soft tissue sarcomas (STSs) are rare malignant tumors of embryogenic mesoderm origin. Primary thoracic STSs account for a small percentage of all…”
Get full text

Prognostic factors for recurrence-free survival in patients with HER2-positive early-stage breast cancer treated with adjuvant trastuzumab by Tonyali, Onder, Coskun, Ugur, Sener, Nur, Inanc, Mevlude, Akman, Tulay, Ulas, Arife, Yazilitas, Dogan, Bal, Oznur, Kucukoner, Mehmet, Yildirim Ozdemir, Nuriye, Demirci, Umut, Gunaydin, Yusuf, Yildiz, Ramazan, Karaca, Halit, Umit Unal, Olcun, Gumus, Mahmut, Benekli, Mustafa, Buyukberber, Suleyman

“…The objective of this study was to identify prognostic factors affecting the recurrence-free survival (RFS) in patients who received a 52-week trastuzumab…”
Get more information

Impact of adjuvant treatment modalities on survival outcomes in curatively resected pancreatic and periampullary adenocarcinoma by Turan, Nedim, Benekli, Mustafa, Unal, Olcun Umit, Unek, İlkay Tugba, Tastekin, Didem, Dane, Faysal, Algın, Efnan, Ulger, Sukran, Eren, Tulay, Topcu, Turkan Ozturk, Turkmen, Esma, Babacan, Nalan Akgül, Tufan, Gulnihal, Urakci, Zuhat, Ustaalioglu, Basak Oven, Uysal, Ozlem Sonmez, Ercelep, Ozlem Balvan, Taskoylu, Burcu Yapar, Aksoy, Asude, Canhoroz, Mustafa, Demirci, Umut, Dogan, Erkan, Berk, Veli, Balakan, Ozan, Ekinci, Ahmet Şiyar, Uysal, Mukremin, Petekkaya, İbrahim, Ozturk, Selçuk Cemil, Tonyalı, Önder, Çetin, Bülent, Aldemir, Mehmet Naci, Helvacı, Kaan, Ozdemir, Nuriye, Oztop, İlhan, Coskun, Ugur, Uner, Aytug, Ozet, Ahmet, Buyukberber, Suleyman

“…We examined the impact of adjuvant modalities on resected pancreatic and periampullary adenocarcinoma (PAC). A total of 563 patients who were curatively…”
Get full text

Impact of HER2-Low Status in Metastatic Gastric Cancer: A Real-World Retrospective Cohort Study by Unal, Olcun Umit, Akay, Seval, Gul, Gurkan, Keser, Murat, Ozamrak, Birsen Gizem, Solakoglu Kahraman, Dudu, Erdogan, Mihriban

“…Information regarding HER2-low tumors in metastatic gastric cancer is sparse. Our aim here was to determine the frequency of low HER2 expression in metastatic…”
Get more information